Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study

Marilyn L. Kwan, Jeanne Darbinian, Kathryn H. Schmitz, Rebecca Citron, Paula Partee, Susan E. Kutner, Lawrence H. Kushi

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Objective: To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle, and clinical factors associated with BCRL development. Design: The Pathways Study, a prospective cohort study of breast cancer survivors with a mean follow-up time of 20.9 months. Setting: Kaiser Permanente Northern California medical care program. Participants: We studied 997 women diagnosed from January 9, 2006, through October 15, 2007, with primary invasive breast cancer and who were at least 21 years of age at diagnosis, had no history of any cancer, and spoke English, Spanish, Cantonese, or Mandarin. Main Outcome Measure: Clinical indication for BCRL as determined from outpatient or hospitalization diagnostic codes, outpatient procedural codes, and durable medical equipment orders. Results: A clinical indication for BCRL was found in 133 women (13.3%), with a mean time to diagnosis of 8.3 months (range, 0.7-27.3 months). Being African American (hazard ratio, 1.93; 95% confidence interval, 1.00-3.72) or more educated (P for trend=.03) was associated with an increased risk of BCRL. Removal of at least 1 lymph node (hazard ratio, 1.04; 95% confidence interval, 1.02-1.07) was associated with an increased risk, yet no significant association was observed for type of lymph node surgery. Being obese at breast cancer diagnosis was suggestive of an elevated risk (hazard ratio, 1.43; 95% confidence interval, 0.88-2.31). Conclusions: In a large cohort study, BCRL occurs among a substantial proportion of early breast cancer survivors. Our findings agree with those of previous studies on the increased risk of BCRL with removal of lymph nodes and being obese, but they point to a differential risk according to race or ethnicity.

Original languageEnglish (US)
Pages (from-to)1055-1063
Number of pages9
JournalArchives of Surgery
Volume145
Issue number11
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Lymphedema
Survival Rate
Breast Neoplasms
Lymph Nodes
Confidence Intervals
Survivors
Durable Medical Equipment
Cohort Studies
Outpatients
Breast Cancer Lymphedema
African Americans
Life Style
Hospitalization
Odds Ratio
Demography
Outcome Assessment (Health Care)
Prospective Studies
Incidence
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Kwan, M. L., Darbinian, J., Schmitz, K. H., Citron, R., Partee, P., Kutner, S. E., & Kushi, L. H. (2010). Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study. Archives of Surgery, 145(11), 1055-1063. https://doi.org/10.1001/archsurg.2010.231

Risk factors for lymphedema in a prospective breast cancer survivorship study : The pathways study. / Kwan, Marilyn L.; Darbinian, Jeanne; Schmitz, Kathryn H.; Citron, Rebecca; Partee, Paula; Kutner, Susan E.; Kushi, Lawrence H.

In: Archives of Surgery, Vol. 145, No. 11, 11.2010, p. 1055-1063.

Research output: Contribution to journalArticle

Kwan, ML, Darbinian, J, Schmitz, KH, Citron, R, Partee, P, Kutner, SE & Kushi, LH 2010, 'Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study', Archives of Surgery, vol. 145, no. 11, pp. 1055-1063. https://doi.org/10.1001/archsurg.2010.231
Kwan, Marilyn L. ; Darbinian, Jeanne ; Schmitz, Kathryn H. ; Citron, Rebecca ; Partee, Paula ; Kutner, Susan E. ; Kushi, Lawrence H. / Risk factors for lymphedema in a prospective breast cancer survivorship study : The pathways study. In: Archives of Surgery. 2010 ; Vol. 145, No. 11. pp. 1055-1063.
@article{e29c156c23124b62925fe49671f6ab44,
title = "Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study",
abstract = "Objective: To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle, and clinical factors associated with BCRL development. Design: The Pathways Study, a prospective cohort study of breast cancer survivors with a mean follow-up time of 20.9 months. Setting: Kaiser Permanente Northern California medical care program. Participants: We studied 997 women diagnosed from January 9, 2006, through October 15, 2007, with primary invasive breast cancer and who were at least 21 years of age at diagnosis, had no history of any cancer, and spoke English, Spanish, Cantonese, or Mandarin. Main Outcome Measure: Clinical indication for BCRL as determined from outpatient or hospitalization diagnostic codes, outpatient procedural codes, and durable medical equipment orders. Results: A clinical indication for BCRL was found in 133 women (13.3{\%}), with a mean time to diagnosis of 8.3 months (range, 0.7-27.3 months). Being African American (hazard ratio, 1.93; 95{\%} confidence interval, 1.00-3.72) or more educated (P for trend=.03) was associated with an increased risk of BCRL. Removal of at least 1 lymph node (hazard ratio, 1.04; 95{\%} confidence interval, 1.02-1.07) was associated with an increased risk, yet no significant association was observed for type of lymph node surgery. Being obese at breast cancer diagnosis was suggestive of an elevated risk (hazard ratio, 1.43; 95{\%} confidence interval, 0.88-2.31). Conclusions: In a large cohort study, BCRL occurs among a substantial proportion of early breast cancer survivors. Our findings agree with those of previous studies on the increased risk of BCRL with removal of lymph nodes and being obese, but they point to a differential risk according to race or ethnicity.",
author = "Kwan, {Marilyn L.} and Jeanne Darbinian and Schmitz, {Kathryn H.} and Rebecca Citron and Paula Partee and Kutner, {Susan E.} and Kushi, {Lawrence H.}",
year = "2010",
month = "11",
doi = "10.1001/archsurg.2010.231",
language = "English (US)",
volume = "145",
pages = "1055--1063",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Risk factors for lymphedema in a prospective breast cancer survivorship study

T2 - The pathways study

AU - Kwan, Marilyn L.

AU - Darbinian, Jeanne

AU - Schmitz, Kathryn H.

AU - Citron, Rebecca

AU - Partee, Paula

AU - Kutner, Susan E.

AU - Kushi, Lawrence H.

PY - 2010/11

Y1 - 2010/11

N2 - Objective: To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle, and clinical factors associated with BCRL development. Design: The Pathways Study, a prospective cohort study of breast cancer survivors with a mean follow-up time of 20.9 months. Setting: Kaiser Permanente Northern California medical care program. Participants: We studied 997 women diagnosed from January 9, 2006, through October 15, 2007, with primary invasive breast cancer and who were at least 21 years of age at diagnosis, had no history of any cancer, and spoke English, Spanish, Cantonese, or Mandarin. Main Outcome Measure: Clinical indication for BCRL as determined from outpatient or hospitalization diagnostic codes, outpatient procedural codes, and durable medical equipment orders. Results: A clinical indication for BCRL was found in 133 women (13.3%), with a mean time to diagnosis of 8.3 months (range, 0.7-27.3 months). Being African American (hazard ratio, 1.93; 95% confidence interval, 1.00-3.72) or more educated (P for trend=.03) was associated with an increased risk of BCRL. Removal of at least 1 lymph node (hazard ratio, 1.04; 95% confidence interval, 1.02-1.07) was associated with an increased risk, yet no significant association was observed for type of lymph node surgery. Being obese at breast cancer diagnosis was suggestive of an elevated risk (hazard ratio, 1.43; 95% confidence interval, 0.88-2.31). Conclusions: In a large cohort study, BCRL occurs among a substantial proportion of early breast cancer survivors. Our findings agree with those of previous studies on the increased risk of BCRL with removal of lymph nodes and being obese, but they point to a differential risk according to race or ethnicity.

AB - Objective: To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle, and clinical factors associated with BCRL development. Design: The Pathways Study, a prospective cohort study of breast cancer survivors with a mean follow-up time of 20.9 months. Setting: Kaiser Permanente Northern California medical care program. Participants: We studied 997 women diagnosed from January 9, 2006, through October 15, 2007, with primary invasive breast cancer and who were at least 21 years of age at diagnosis, had no history of any cancer, and spoke English, Spanish, Cantonese, or Mandarin. Main Outcome Measure: Clinical indication for BCRL as determined from outpatient or hospitalization diagnostic codes, outpatient procedural codes, and durable medical equipment orders. Results: A clinical indication for BCRL was found in 133 women (13.3%), with a mean time to diagnosis of 8.3 months (range, 0.7-27.3 months). Being African American (hazard ratio, 1.93; 95% confidence interval, 1.00-3.72) or more educated (P for trend=.03) was associated with an increased risk of BCRL. Removal of at least 1 lymph node (hazard ratio, 1.04; 95% confidence interval, 1.02-1.07) was associated with an increased risk, yet no significant association was observed for type of lymph node surgery. Being obese at breast cancer diagnosis was suggestive of an elevated risk (hazard ratio, 1.43; 95% confidence interval, 0.88-2.31). Conclusions: In a large cohort study, BCRL occurs among a substantial proportion of early breast cancer survivors. Our findings agree with those of previous studies on the increased risk of BCRL with removal of lymph nodes and being obese, but they point to a differential risk according to race or ethnicity.

UR - http://www.scopus.com/inward/record.url?scp=78449251556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449251556&partnerID=8YFLogxK

U2 - 10.1001/archsurg.2010.231

DO - 10.1001/archsurg.2010.231

M3 - Article

C2 - 21079093

AN - SCOPUS:78449251556

VL - 145

SP - 1055

EP - 1063

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 11

ER -